Early stage biotechnology collaborations The range of deals an early stage biotechnology company may enter into is wide (see box […]

FDA chief looks to speed diabetes, obesity drugs Mark McClellan, commissioner of the Food and Drug Administration, said he wants

Pfizer sues over counterfeit Lipitor Pfizer Inc. said Tuesday it was suing two companies connected to counterfeit versions of its

The ImClone Story: A Hyped Drug, a Tainted Icon It was, in retrospect, a festival of hype emblematic of the

Five Hurdles for Biotech The science is hot and the stocks are up. Here’s what’s needed to deliver on the

San DNAgo Thanks to a fruitful partnership of academia and private enterprise, a vibrant biotech industry keeps on replicating itself.

Puncturing The ImClone Hype Could ImClone Systems’ Erbitux be a powerful cancer fighter after all? Maybe. A new study presented

China’s Killer Headache: Fake Pharmaceuticals An estimated 192,000 people died last year in China because of fake drugs, according to

China’s Killer Headache: Fake Pharmaceuticals An estimated 192,000 people died last year in China because of fake drugs, according to

Looking beyond Patent Expiry The problem of patent protection loss and associated revenue loss will continue to trouble major companies,